Company · CIK 0000874015 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
IONIS PHARMACEUTICALS INC · IONS
Insider activity reported against this company. All insider holders · Files at: AKCA, RGLS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 JForm 4 → | Sep 2, 8:32 pm EDT | C Frank BennettEVP, Chief Scientific Officer | 110 | $51.31 | $5,644 | 60,128 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Patrick R. O'NeilEVP CLO & General Counsel | 63 | $51.31 | $3,232 | 59,205 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Brett P MoniaChief Executive Officer, Director | 98 | $51.31 | $5,028 | 242,760 | — | |
| Aug 31, 2026 JForm 4 → | Sep 2, 8:22 pm EDT | Brian BirchlerEVP, Corp and Development Ops | 58 | $51.31 | $2,976 | 102,883 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.